When Hameeda Sultana's team at the University of Tennessee College of Veterinary Medicine silenced a single tick gene, the consequences rippled across every step of disease transmission—ticks struggled to feed, their bodies grew lighter, and viral loads plummeted. This discovery, published in The EMBO Journal, points toward a radical new approach to stopping tick-borne illness: not by attacking viruses or reducing tick populations, but by sabotaging the microscopic machinery ticks rely on to infect their hosts in the first place.
Ticks are among nature's most efficient disease vectors. Each year, these tiny parasites spread viruses and bacteria that sicken humans, livestock, wildlife, and pets worldwide. Yet their success hinges on a feat of molecular deception—when a tick pierces skin to feed, its saliva is far more than a simple anesthetic. Sultana's research team discovered that tick saliva contains exosomes: bubble-like vesicles packed with a sophisticated cocktail of proteins. These microscopic vessels act as Trojan horses, carrying molecules that help ticks feed undetected while simultaneously creating pathways for viruses to slip from tick to host.
The breakthrough centered on a specific exosomal protein—a glycine-rich molecule essential to this entire process. When postdoctoral fellow Waqas Ahmed and colleagues used genetic tools to silence the gene encoding this protein, the results were unmistakable. Ticks lacking the protein were significantly less effective at feeding and weighed less after attempting to do so. Most critically, virus levels inside these ticks dropped dramatically. "Exosomes are tiny bubble-like vesicles with messages in them," Sultana explains. "They are tiny membrane-bound particles that transport proteins and other biological signals between cells and tissues."
This work builds on Sultana's groundbreaking 2018-2020 research, when her laboratory first identified exosomes derived from tick saliva and salivary glands. Over the past few years, she and collaborators including graduate students Wenshuo Zhou and Kehinde Fasae, current student Md Bayzid, and faculty partners Girish Neelakanta and former clinical assistant professor Denae LoBato have steadily uncovered how ticks deploy these vesicles as weapons.
The implications reach far beyond understanding tick biology. This protein could become the foundation for a transmission-blocking vaccine—an entirely different category of protection than conventional vaccines. Rather than targeting the virus itself, such a vaccine would target molecules within the tick, preventing it from successfully feeding or transmitting pathogens in the first place. By interrupting transmission at this early stage, infections might be stopped before they ever reach a human or animal host.
"Targeting this type of protein might be an ideal approach to affect transmission of several pathogens from ticks," says Neelakanta, highlighting how this strategy could address multiple tick-borne diseases simultaneously. As tick populations expand and disease incidence climbs globally, conventional prevention methods—avoiding ticks or controlling populations—have proven insufficient.
Sultana sees this discovery as opening a new frontier. "Since the identification of exosomes from ticks from my laboratory, several studies—including our own—have emphasized the importance of these vesicles in tick feeding and interactions with pathogens," she says. "This is an exciting area of research that could open several avenues for the development of arthropod exosome-based strategies to target vector-borne diseases." The next phase will determine whether this laboratory breakthrough can translate into a practical vaccine strategy—and whether targeting microscopic vesicles might finally tip the scales against one of nature's most persistent disease carriers.